Filing Details

Accession Number:
0001415889-22-012650
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2022-12-19 07:08:15
Reporting Period:
2022-11-25
Accepted Time:
2022-12-19 07:08:15
Original Submission Date:
2022-11-28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1719406 Nrx Pharmaceuticals Inc. NRXP () 4/A
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1284934 Seth Voorhees Van C/O Nrx Pharmaceuticals Inc
1201 N. Market Street, Suite 111
Wilmington DE 19801
Chief Financial Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.001 Per Share Acquisiton 2022-11-25 8,716 $1.12 8,716 No 4 P Direct
Common Stock, Par Value $0.001 Per Share Acquisiton 2022-11-25 600 $1.10 9,316 No 4 P Direct
Common Stock, Par Value $0.001 Per Share Acquisiton 2022-11-25 7,021 $1.11 16,337 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
Footnotes
  1. The form of ownership has been changed from Indirect to Direct. The original Form 4 stated that these shares were purchased though a 401(k) plan. This Form 4/A is being filed to correct this error.
  2. The form of ownership has been changed from Indirect to Direct. The original Form 4 stated that these shares were purchased though a 401(k) plan. This Form 4/A is being filed to correct this error.
  3. Total number of shares held is reduced by 40 shares to correct an arithmetic error in the original Form 4.
  4. The form of ownership has been changed from Indirect to Direct. The original Form 4 stated that these shares were purchased though a 401(k) plan. This Form 4/A is being filed to correct this error.